Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 34 Carcinoma, Non-Small-Cell Lung 26 Breast Neoplasms 26 Lung Neoplasms 24 Colonic Neoplasms 18 Head and Neck Neoplasms 16 Rectal Neoplasms 14 Prostatic Neoplasms 11 Sarcoma 10 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Neoplasms 7 Mouth Neoplasms 7 Melanoma 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Ovarian Neoplasms 6 Glioblastoma 6 Precancerous Conditions 5 Neuroblastoma 5 Liver Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4

Interventions

pembrolizumab 7 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Rosuvastatin Calcium 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 osimertinib 1 niraparib 1 neotil 1 necitumumab 1 mirdametinib 1 leronlimab 1 lenvatinib 1 atezolizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × Celecoxib × Clear all

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡